Data / Form D filings / Carna Inc.
Carna Inc.: Form D filings
Carna Inc., a biotechnology company in Boston, MA, filed 2 Form D notices with the SEC between 2025 and 2026. The latest, on June 11, 2026, reports $9.1 million sold of a $10 million offering to 27 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 200 NEWBURY STREET SUITE 401, Boston, MA, 02116
- Phone
- (617) 966-1055
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- $1 - $1,000,000
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 2055006
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | Amendment | $10,000,000 | $9,073,160 | $926,840 | 27 | Jan 3, 2025 | sec.gov |
| Feb 5, 2025 | New notice | $10,000,000 | $3,400,000 | $6,600,000 | 13 | Jan 3, 2025 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Salvatore Viscomi | Executive Officer, Director, Promoter | |
| Boris Berat | Executive Officer, Director, Promoter | |
| Michelle Longmire | Director | |
| David Vogel | Promoter | |
| Juan Marichal | Promoter | |
| Faisal Rusho | Executive Officer | |
| Justin Nguyen | Executive Officer | |
| Jose Pereyra | Director, Promoter |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Jun 8, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Carna Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.